| GO Term Name | (GO Accession Number) | Term Type | Definition |
| positive regulation of antimicrobial peptide production | (GO:0002225) | biological_process | Any process that activates or increases the frequency, rate, or extent of antimicrobial peptide production. |
| antimicrobial peptide production | (GO:0002775) | biological_process | The synthesis or release of an antimicrobial peptide during an immune response, resulting in an increase in intracellular or extracellular levels. Such peptides may have protective properties against bacteria, fungi, viruses, or protozoa. |
| antimicrobial peptide secretion | (GO:0002776) | biological_process | The regulated release of an antimicrobial peptide from a cell or a tissue. Such peptides may have protective properties against bacteria, fungi, viruses, or protozoa. |
| antimicrobial peptide biosynthetic process | (GO:0002777) | biological_process | The chemical reactions and pathways resulting in the formation of an antimicrobial peptide. Such peptides may have protective properties against bacteria, fungi, viruses, or protozoa. |
| regulation of antimicrobial peptide production | (GO:0002784) | biological_process | Any process that modulates the frequency, rate, or extent of antimicrobial peptide production. |
| negative regulation of antimicrobial peptide production | (GO:0002785) | biological_process | Any process that stops, prevents, or reduces the frequency, rate, or extent of antimicrobial peptide production. |
| regulation of antimicrobial peptide secretion | (GO:0002794) | biological_process | Any process that modulates the frequency, rate, or extent of antimicrobial peptide secretion. |
| negative regulation of antimicrobial peptide secretion | (GO:0002795) | biological_process | Any process that stops, prevents, or reduces the frequency, rate, or extent of antimicrobial peptide secretion. |
| positive regulation of antimicrobial peptide secretion | (GO:0002796) | biological_process | Any process that activates or increases the frequency, rate, or extent of antimicrobial peptide secretion. |
| regulation of antimicrobial peptide biosynthetic process | (GO:0002805) | biological_process | Any process that modulates the frequency, rate, or extent of antimicrobial peptide biosynthesis. |
| negative regulation of antimicrobial peptide biosynthetic process | (GO:0002806) | biological_process | Any process that stops, prevents, or reduces the frequency, rate, or extent of antimicrobial peptide biosynthesis. |
| positive regulation of antimicrobial peptide biosynthetic process | (GO:0002807) | biological_process | Any process that activates or increases the frequency, rate, or extent of antimicrobial peptide biosynthesis. |
| obsolete antimicrobial peptide activity | (GO:0003795) | molecular_function | OBSOLETE. Inhibits the growth of, or directly kills, microbial cells. This term was made obsolete because it describes involvement in a process and not a function. |
| antimicrobial humoral immune response mediated by antimicrobial peptide | (GO:0061844) | biological_process | An immune response against microbes mediated by anti-microbial peptides in body fluid. |
| defense response | (GO:0006952) | biological_process | Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack. |
| peptidoglycan recognition protein signaling pathway | (GO:0061057) | biological_process | A series of molecular signals initiated by binding of peptidoglycan to a receptor on the surface of the target cell and ending with regulation of a downstream cellular process. The main outcome of the Imd signaling is the production of antimicrobial peptides. |
| beta-L-Ara4N-lipid A biosynthetic process | (GO:1901760) | biological_process | The chemical reactions and pathways resulting in the formation of beta-L-Ara4N-lipid A which occurs as a result of modification of the lipid A moiety of lipopolysaccharide by the addition of the sugar 4-amino-4-deoxy-L-arabinose (L-Ara4N). This strategy is adopted by pathogenic Gram-negative bacteria to evade cationic antimicrobial peptides produced by the innate immune system. |
